Evidence map›Paper›PMID 40104707›Full record

ArticleTranslational cancer research2025

Wei Zhou, Qianli Tang, Jun Wu, Minyu Huang, Qun Huang, Tianzi Qin, Ning Tang, Shasha Gai

Abstract read
In one paragraph

Article in Translational cancer research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Wei ZhouGraduate School of the First Clinical Medical College of Jinan University, Guangzhou, China.ORCID https://orcid.org/0009-0006-6395-1219
Qianli TangKey Laboratory of Tumor Molecular Pathology of Baise, Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, China.
Jun WuDepartment of Urology, the Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, China.
Minyu HuangDepartment of Urology, the Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, China.
Qun HuangDepartment of Urology, the Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, China.
Tianzi QinDepartment of Urology, the Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, China.
Ning TangGraduate School of Youjiang Medical University for Nationalities, Baise, China.
Shasha GaiGraduate School of Youjiang Medical University for Nationalities, Baise, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Clear cell renal cell carcinoma (ccRCC), a malignant neoplasm originating in the renal tubules, is characterized by extended treatment durations and suboptimal therapeutic outcomes in clinical settings. Adenosine triphosphate (ATP) synthase F1 subunit α ( Methods: The RNA sequencing data from ccRCC and corresponding adjacent tissues were analyzed through The Cancer Genome Atlas to evaluate their diagnostic and prognostic implications. Results: Conclusions: Collectively, this study indicates that

Indexed as

Adenosine triphosphate synthase F1 subunit α (ATP5A1)bioinformatic analysisbiomarkerclear cell renal cell carcinoma (ccRCC)

Identifiers

PMID40104707
PMCPMC11912089

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.